Diltiazem Hydrochloride

Diltiazem Hydrochloride is used to treat variant angina pectoris, atrial fibrillation, atrial flutter, hypertension, myocardial infarction and supraventricular tachycardia, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Nov 5, 1982, and the first generic was approved Nov 5, 1992. FDA's Orange Book lists 136 AB-rated (therapeutically equivalent) products for this ingredient.

Diltiazem Hydrochloride is available as 238 NDCs from 24 manufacturers (217 generic, 21 brand), with NADAC prices from $0.05 to $79.31 per EA — the most expensive product costs about 1,601× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.